Skip to main content

James

Analyst

Jefferies

Equibles does not estimate personal net worth.

About James

James is recorded as Analyst at Jefferies. James has spoken on 8 earnings calls and 1 other investor event across 7 companies, most recently for Rigel Pharmaceuticals Inc on November 5, 2026. Those appearances were for Hayward Holdings, Inc. (HAYW), Rigel Pharmaceuticals Inc (RIGL), Tango Therapeutics, Inc. (TNGX), Sangamo Therapeutics, Inc (SGMOQ), Taysha Gene Therapies, Inc. (TSHA) and 2 other companies. The companies whose calls James spoke on are classified in the Industrials and Healthcare sectors.

James on recent calls

“I guess I wanted to touch on the olibuy and can you just kind of help me understand what is like driving the growth in olibuy as of now when the market really hasn't inflected here and you talked about distributors being more prudent on kind of working capital management and I think the pricing ran higher so I think…”
Analyst — Jefferies, Hayward Holdings, Inc. Third Quarter 2026 Earnings ·
“Going back to the data, can you provide more detail on the 40% dose interruption and 20% dose reduction rates at dose level 1, including the duration of interruptions and whether the modifications involved both the diraxone RASIB or Vopimetastat and the doses to which patients were reduced?”
Analyst — Jefferies, Tango Therapeutics Conference Call ·
“Given that the last patient reached the two-year time point around April, can you walk us through the gating factors for analyzing that data set and disclosing the data set?”
Analyst — Jefferies, Sangamo Therapeutics, Inc Q1 FY2026 Earnings Call ·
“For the 12-plus months of follow-up in the 2Q update, how are you setting expectations for the early milestones and skills deepening versus new, more complex milestones and skills appearing between 6 and 12 months?”
Analyst — Jefferies, Taysha Gene Therapies, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

  • Jefferies

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity